Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006360 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
A Phase 1 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00006360 is a Phase 1 study that has completed, run by Radiation Therapy Oncology Group.
The verdict
NCT00006360, a Phase 1 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III oropharyngeal cancer.
Interventions
- RADIATION radiation therapy
- DRUG radioprotection
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-02 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006360
The ClinicalTrials.gov registry entry for NCT00006360 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.
NCT00006360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006360 about?
NCT00006360 is a clinical study titled "Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III oropharyngeal cancer.
What is the current status of trial NCT00006360?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00006360?
The interventions under investigation include: radiation therapy (RADIATION), radioprotection (DRUG).
Who is sponsoring clinical trial NCT00006360?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.